Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Collegium Pharmaceutical Inc.

www.collegiumpharma.com

Latest From Collegium Pharmaceutical Inc.

FDA Warns Lymol To Assess Talc Lead Risk Per ICH Q3D; Puts Others On Notice

A warning letter to firm with legacy talc drug product puts pharmaceutical industry on notice: the US FDA expects applicants to meet requirements agency imposes post-approval for matters like elemental impurities compliance.

Enforcement Quality

Ascend’s EstroGel Promotion Misrepresents Efficacy Compared To Other Products, US FDA Says

Professional sell sheet falsely suggests estradiol gel contains lowest effective dose of estrogen compared to other estrogen products, OPDP says in fourth “untitled” letter of 2018.


Advertising, Marketing & Sales Compliance

US FDA Reprimands Arog Pharmaceuticals For Promo Of Investigational AML Drug

Third enforcement letter of the year cites meeting exhibit and webpage that suggest crenolanib is safe and effective for an unapproved use.

Advertising, Marketing & Sales Enforcement

Remoxy Review Shows How Opana ER Experience Changed US FDA Thinking On New Opioid Formulations

Pain Therapeutics CEO Barbier says comparing Remoxy to Endo's withdrawn Opana ER 'borders on slanderous' and asserts that after three complete response letters, FDA is once again moving goalposts for approval.

Advisory Committees Drug Safety
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Collegium Pharmaceutical Inc.
  • Senior Management
  • Michael Heffernan, Pres. & CEO
    Paul Brannelly, EVP, CFO
    John Weet, PhD, VP, Reg. Affairs & Quality Assurance
    Joseph Ciaffoni, EVP, COO
    Raimonds Dzelme, VP, Mktg.
    Jack Maroney, VP, Sales
    Alison B Fleming, PhD, CTO
    Richard Malamut, MD, CMO
  • Contact Info
  • Collegium Pharmaceutical Inc.
    Phone: (781) 713-3699
    780 Dedham St.
    Ste. 800
    Canton, MA 02021
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register